<DOC>
	<DOCNO>NCT02807675</DOCNO>
	<brief_summary>This study double-blind , randomize , placebo-controlled , 2-way crossover study evaluate safety CVT-301 levodopa ( l-dopa ) co- administer first daily dose oral levodopa/carbidopa early morning OFF symptoms patient Parkinson 's disease ( PD ) .</brief_summary>
	<brief_title>A Study Safety Tolerability Single Dose Administration CVT-301 ( Levodopa Inhalation Powder )</brief_title>
	<detailed_description>An `` OFF state '' define time medication longer provide benefit respect mobility , slowness , stiffness . OFF episodes may herald non-motor symptom ( e.g. , pain , anxiety ) prior appearance motor symptom .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>idiopathic PD ( i.e. , induce drug disease ) define fulfil Steps 1 2 United Kingdom ( UK ) Brain Bank criterion , diagnose age 30 year diagnosis Parkinson 's disease motor fluctuation early morning OFF symptom classify Stage 1 3 modify Hoehn Yahr scale stag PD severity ( ON state ) subject ldopacontaining therapy , include Rytary ( equivalent ) , must stable oral ldopacontaining therapy least 2 week prior Screening Visit ldopa/decarboxylase inhibitor ( DDI ) contain regimen subject ldopacontaining therapy , include Rytary ( equivalent ) , stable dose least 6 week prior Screening Visit frequency ldopa administration must least 3 time wake day total daily ldopa dose ≤ 1600 mg. stable regimen standard PD medication stable regimen blood pressure reduce medication ( applicable ) least 30 day prior screen force expiratory volume one second ( FEV1 ) ≥60 % predict race , age , sex , height FEV1/FVC ( force vital capacity ) ratio ≥70 % clinically significant abnormality would affect ability complete study determine medical history , physical examination , electrocardiogram , clinical laboratory test result negative drug alcohol test negative pregnancy test woman . participate prior study CVT301 dyskinesia severity would significantly interfere subject 's ability participate perform study procedure ( determine UPDRS Part 4 ) contraindication perform routine spirometry unable perform spirometry maneuver current history symptomatic orthostatic hypotension treat medication treat orthostatic hypotension ( example droxidopa , fludrocortisone ) , severe dysautonomia chronic obstructive pulmonary disease ( COPD ) , asthma , another chronic respiratory disease within last 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>